Jose Luis Pelaez Inc/DigitalVision via Getty Images As the AI hype bubble continues to deflate, fears about a potential US recession intensify, and risks of a large-scale war in the Middle East remain, Teva Pharmaceutical's stock price (NYSE:TEVA) is moving in an accumulation phase above $17, reflecting the continued strength of the bulls. What are the reasons for Wall Street's growing optimism about the Israeli company, which is one of the leaders in the generic drug market? First, on July 31, Teva release ...